Bionova Capital
ABOUT BIONOVA CAPITAL
Bionova Capital is a Lisbon-based venture capital firm founded in 2015 that specializes in healthcare and life sciences with a European scope. It invests at the early stage across healthcare, biotech, deep tech, and life sciences, backing companies developing diagnostics, therapeutics, medical devices, and health-tech platforms with strong science and clear regulatory pathways. Bionova Capital's portfolio includes Adapttech, Anybrain, and CellmAbs, the latter an exit, along with Delox, SolasCure, Vaxdyn, and Oxular. The firm records two exits to date. It is led by CEO Ricardo Perdigão Henriques and Chairman Peter Villax, with João Botelho as Finance Director. Bionova Capital is currently making no new investments and is managing its existing portfolio only, continuing to support the science-led healthcare and life sciences companies it has already backed rather than deploying into new deals.
INVESTMENT THESIS
Healthcare and life sciences specialist. Backs companies developing diagnostics, therapeutics, medical devices, and health-tech platforms with strong science and clear regulatory pathways.
INVESTMENT DETAILS
CONNECT
FREQUENTLY ASKED QUESTIONS
What stage does Bionova Capital invest at?
Bionova Capital invests at Early Stage stage.
What sectors does Bionova Capital invest in?
Bionova Capital focuses on Healthcare, Biotech, Deep Tech, Life Sciences.
Where is Bionova Capital based?
Bionova Capital is a VC based in Lisbon, Portugal, founded in 2015.
Who are the partners at Bionova Capital?
Key people at Bionova Capital include Ricardo Perdigão Henriques (CEO), Peter Villax (Chairman), João Botelho (Finance Director).
What companies has Bionova Capital invested in?
Bionova Capital's portfolio includes Anybrain, CellmAbs, Adapttech, Delox, SolasCure, Vaxdyn, Oxular.
Is Bionova Capital actively investing?
No new investments, portfolio only.
How do I contact or pitch Bionova Capital?
You can reach Bionova Capital via their website (bionovacapital.com). You can also submit your startup through Portugal VC's pitch tool to be forwarded to matching investors.